Nov 1 (Reuters) - Scandinavian Real Heart AB HEART.ST :
* REALHEART HAS SUCCESSFULLY ESTABLISHED A NOVEL TEST SYSTEM
TO
EVALUATE HEMOLYSIS OF ITS TOTAL ARTIFICIAL HEART
* INITIAL TEST RESULTS SHOW THAT CO'S ARTIFICIAL HEART
INDUCES 80%
LESS HEMOLYSIS COMPARED TO CURRENT MARKET LEADER
* WILL SHORTLY START EVALUATION OF HEMOLYTIC EVENTS USING
CLINICAL
VERSION OF PRODUCT
Source text for Eikon: ID:nWkr1cxqmL
Further company coverage: HEART.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))